Differential roles for nicotinic and muscarinic cholinergic receptors in sustained visuo-spatial attention? A study using a 5-arm maze protocol in mice

Behavioural Brain Research

Volumn 128, Issue 1, 2002, Pages 91-102

  Leblond, Laurent ^a   Beaufort, Christine ^a   Delerue, Fabien ^a   Durkin, Thomas P ^a  

^a CNRS   (France)

Author keywords

5 Arm maze; Mecamylamine; Mouse; Muscarinic receptors; Nicotinic receptors; Scopolamine; Sustained visuo spatial attention

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT; MECAMYLAMINE; MUSCARINIC RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT; SCOPOLAMINE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ARM; ARTICLE; ATTENTION; CONTROLLED STUDY; DEPTH PERCEPTION; DIAGNOSTIC TEST; EVALUATION; HYPOTHESIS; LATENT PERIOD; LATIN SQUARE DESIGN; MALE; MAZE TEST; MEMORY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT STRAIN; TASK PERFORMANCE; TIME PERCEPTION; VISUAL DISCRIMINATION;

ANIMALS; ATTENTION; MALE; MAZE LEARNING; MECAMYLAMINE; MICE; MICE, INBRED C57BL; MUSCARINIC ANTAGONISTS; NICOTINIC ANTAGONISTS; PSYCHOMOTOR PERFORMANCE; RECEPTORS, MUSCARINIC; RECEPTORS, NICOTINIC; SCOPOLAMINE; SPACE PERCEPTION;

EID: 0037033226     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-4328(01)00306-0     Document Type: Article

References (84)

1. Effects of disrupting the cholinergic system on short-term spatial memory in rats
2. Comparative alterations of nicotinic and muscarinic binding sites in Alzheimer's and Parkinson's disease
3. Cognitive functions of the basal forebrain
4. Scopolamine degrades spatial working memory but spares spatial reference memory: Dissimilarity of anticholinergic effects and restriction of distal visual cues
5. Scopolamine impairs encoding and retrieval of spatial working memory in rats
6. Patterns of memory failure after scopolamine treatment: Implications for cholinergic hypotheses of dementia
7. Characterisation of the effects of nicotine in the five-choice serial reaction time task in rats: Antagonist studies
8. The pharmacology of (-) nicotine and novel cholinergic channel modulators
9. Cognitive effects of nicotinic cholinergic receptor agonists in nonhuman primates
10. Detection of visual signals by rats: Effects of chlordiazepoxide and cholinergic and adrenergic drugs on sustained attention
11. Comparative behavioral and neurochemical activities of cholinergic antagonists in rats
12. Effects of lesions to ascending noradrenergic neurones on performance of a 5-choice serial reaction task: Implications for theories of dorsal noradrenergic bundle function based on selective attention and arousal
13. A re-examination of the role of basal forebrain cholinergic neurons in spatial working memory
14. Scopolamine disrupts maintenance of attention rather than memory processes
15. Neuronal nicotinic receptors, important new players in brain function
16. Cholinergic function and intellectual decline in Alzheimer's disease
17. Nicotinic receptors in human brain: Topography and pathology
18. Comparative effects of cholinergic drugs and lesions of nucleus basalis or fimbria-fornix on delayed matching in rats
19. Spatial working memory over long retention intervals: Dependence on sustained cholinergic activation in the septo-hippocampal or nucleus basalis magnocellularis-cortical pathways?
20. Do central nicotinic and muscarinic cholinergic receptors play differential roles in attentional and episodic memory mechanisms? A study using a new 5-arm maze protocol
21. A 5-arm maze enables parallel measures of sustained visuo-spatial attention and spatial working memory in mice
22. Trans-synaptic mechanisms controlling cholinergic neuronal activation in the septo-hippocampal and nBM-cortical cholinergic pathways: Differential roles in memory and attentional processes?
23. Raised glucose levels enhance scopolamine-induced acetylcholine overflow from the hippocampus: An in vivo microdialysis study in the rat
24. Nicotine enhances delayed matching to sample performance by primates
25. Central cholinergic systems and cognition
26. Scopolamine effects on memory retention in mice: A model of dementia?
27. Loss of high affinity agonist binding to M1 muscarinic receptors in Alzheimer's disease. Implications for the failure of cholinergic replacement therapies
28. Sustained visual attention performance-associated prefrontal neuronal activity: Evidence for cholinergic modulation
29. Nicotinic and muscarinic receptors in the rat prefrontal cortex: Differential roles in working memory, response selection and effortful processing
30. Effect of subtype selective nicotinic compounds on attention as assessed by the five-choice serial reaction time task
31. The cholinergic hypothesis of memory: A review of animal experiments
32. The role of the central cholinergic projections in cognition: Implications of the effects of scopolamine on discrimination learning by monkeys
33. Cholinergic modulation of memory in rats
34. Neuromodulation and cortical function: Modeling the physiological basis of behavior
35. Effects of scopolamine on a novel choice serial reaction time task
36. Increases in cortical acetylcholine release during sustained attention performance in rats
37. Visuospatial attentional functioning in mice: Interactions between cholinergic manipulations and genotype
38. Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer's disease
39. Effects of scopolamine on visual attention in rats
40. Nicotinic receptors in the brain: Correlating physiology with function
41. Stimulant drugs and vigilance performance: A review
42. A new five arm maze for testing both attention and episodic memory in mice: Differential roles for central nicotinic and muscarinic cholinergic receptors?
43. Nicotinic systems and cognitive function
44. Transdermal nicotine effects on attention
45. Acute nicotine interactions with nicotinic and muscarinic antagonists: Working and reference memory effects in the 16-arm radial maze
46. Effects of combined muscarinic and nicotinic blockade on choice accuracy in the radial-arm maze
47. Characterization of the cognitive effects of combined muscarinic and nicotinic blockade
48. Development of nicotinic drug therapy for cognitive disorders
49. Nicotinic acetylcholine involvement in cognitive function in animals
50. Combined nicotinic and muscarinic blockade in elderly normal volunteers: Cognitive, behavior, and physiologic responses
51. Selective effects of nicotine on attentional processes
52. Differential roles for central nicotinic and muscarinic receptors in long-term working memory in mice: A study using a 5-arm maze
53. Crossmodal divided attention in rats effects of chlordiazepoxide and scopolamine
54. Behavioural vigilance following infusions of 192 IgG-saporin into the basal forebrain: Selectivity of the behavioural impairment and relation to cortical AChE-positive fiber density
55. Nicotine enhances sustained attention in the rat under specific task conditions
56. The role of nicotinic and muscarinic acetylcholine receptors in attention
57. Characteristics of memory impairment following lesioning of the basal forebrain and medial septal nucleus in rats
58. AMPA-induced excitotoxic lesions of the basal forebrain: A significant role for the cortical cholinergic system in attentional function
59. Excitotoxic lesions of basal forebrain cholinergic neurones: Effects on learning, memory and attention
60. Acute nicotinic blockade produces cognitive impairment in normal humans
61. Nicotinic system involvement in Alzheimer's disease and Parkinson's disease. Implications for therapeutics
62. Hippocampus, space and memory
63. Mnemonic functions of the cholinergic septo-hippocampal system
64. Nicotine impairs spatial working memory while leaving spatial attention intact
65. Neuronal nicotinic receptors in the human brain
66. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia
67. Attention and executive deficits in Alzheimer's disease: A critical review
68. Nicotinic receptors in the brain: Links between molecular biology and behavior
69. Improvement in accuracy of delayed recall in aged and non-aged, mature monkeys after intramuscular or transdermal administration of the CNS nicotinic receptor agonist ABT-418
70. The effects of nicotine on attention, information processing and short-term memory in patients with dementia of the Alzheimer type
71. Retrieval of well-learned propositional rules: Insensitive to changes in activity of individual neurotransmitter systems
72. Cognitive functions of cortical acetylcholine: Towards a unifying hypothesis
73. Cortical cholinergic inputs mediating arousal, attentional processing and dreaming: Differential afferent regulation of the basal forebrain by telencephalic and brainstem afferents
74. The role of attention in a spatial memory task in Alzheimer disease patients
75. Nicotine in an animal model of attention
76. Time gradient for post-test vulnerability to scopolamine-induced amnesia following the initial acquisition session of a spatial reference memory task in mice
77. Cortical acetylcholine and processing capacity: Effects of cortical cholinergic differentiation on crossmodal divided attention in rats
78. Muscarinic acetylcholine receptors in the hippocampus, neocortex and amygdala: A review of immunocytochemical localization in relation to learning and memory
79. Modulatory role of presynaptic nicotinic receptors in synaptic and non-synaptic chemical communication in the central nervous system
80. Basal forebrain lesions in monkeys disrupt attention but not learning and memory
81. Basal forebrain cholinergic neurones and Alzheimer's disease
82. The separate and combined effects of scopolamine and nicotine on human information processing
83. Effects of scopolamine on stimulus sensitivity and response bias in a visual vigilance task
84. Alzheimer's disease and senile dementia; loss of neurons in the basal forebrain